scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1024828183 |
P356 | DOI | 10.1245/S10434-014-4231-3 |
P698 | PubMed publication ID | 25391265 |
P5875 | ResearchGate publication ID | 268232868 |
P50 | author | Mikito Inokuchi | Q43070871 |
P2093 | author name string | Kazuyuki Kojima | |
Masatoshi Nakagawa | |||
Sho Otsuki | |||
Kenichi Sugihara | |||
Hiroyuki Uetake | |||
Keiji Kato | |||
Yoko Takagi | |||
Hirofumi Sugita | |||
P2860 | cites work | Global cancer statistics, 2002 | Q27860562 |
Eph-ephrin bidirectional signaling in physiology and disease | Q29617975 | ||
Eph receptors and ephrins in cancer: bidirectional signalling and beyond | Q34021365 | ||
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer | Q34557318 | ||
EphA4 is a prognostic factor in gastric cancer | Q34759687 | ||
Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes | Q35831837 | ||
Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system | Q36393096 | ||
Hypoxia signalling in cancer and approaches to enforce tumour regression | Q36488739 | ||
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia | Q37044749 | ||
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target | Q37149210 | ||
EPH-EPHRIN in human gastrointestinal cancers | Q37824603 | ||
Angiogenesis and tumor microenvironment: bevacizumab in the breast cancer model | Q38245841 | ||
EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells | Q39880948 | ||
Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients | Q39902600 | ||
Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis | Q39916249 | ||
Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma | Q40099499 | ||
HER-2/neu amplification is an independent prognostic factor in gastric cancer. | Q40303656 | ||
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application | Q40554993 | ||
Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors | Q41875227 | ||
High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease | Q44108600 | ||
Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression | Q44732912 | ||
Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer | Q44765392 | ||
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization | Q46699319 | ||
Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer. | Q54346430 | ||
Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer. | Q54685952 | ||
Unified Nomenclature for Eph Family Receptors and Their Ligands, the Ephrins | Q55865952 | ||
P433 | issue | 7 | |
P921 | main subject | erythropoietin | Q218706 |
P304 | page(s) | 2329-2335 | |
P577 | publication date | 2014-11-13 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | Erythropoietin-Producing Hepatocellular A1 is an Independent Prognostic Factor for Gastric Cancer | |
P478 | volume | 22 |
Q47159601 | Cancer risk susceptibility loci in a Swedish population |
Q33612699 | High expression of EphA3 (erythropoietin-producing hepatocellular A3) in gastric cancer is associated with metastasis and poor survival. |
Q36309934 | Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies |
Q64092279 | Serum biomarker panels for the diagnosis of gastric cancer |
Q102075461 | Silencing of long non-coding RNA XIST represses gastric cancer progression through blocking NFκB pathway via inhibiting HNF4A-mediated transcription of EPHA1 |
Search more.